Home › Peripheral Arterial Disease › Pennsylvania
Peripheral Arterial Disease clinical trials in Pennsylvania
10 studies for Peripheral Arterial Disease are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Passive Calf Stretching Therapy in Peripheral Artery Disease
- Penn State University, University Park
Recruiting
Ages 40 to 85 · All sexes · Updated Oct 2, 2026 · NCT06041880Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Capital Area Research, LLC, Camp Hill
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
- The Pennsylvania State University and The Milton S. Hershey Medical Center, Hershey
- Allegheny General Hospital, Pittsburgh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07322913The THOR IDE Study
- UPMC, Mechanicsburg
- Hospital of the University of Pennsylvania, Philadelphia
- Lankenau Institute for Medical Research, Wynnewood
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05916950The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT05811364Serranator POINT FORCE Registry
- Jefferson Einstein, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT06687590MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RecruitingPhase 3
Ages 35 to 89 · All sexes · Updated Apr 21, 2026 · NCT05132439PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 95 · All sexes · Updated Apr 16, 2026 · NCT05313165Improving Mobility After Revascularization in Peripheral Artery Disease
- University of Pittsburgh, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 26, 2025 · NCT06686121From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.